Cite
HARVARD Citation
Sultan, M. et al. (2021). An in vivo genome‐wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancer. Molecular oncology. 15 (8), pp. 2046-2064. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sultan, M. et al. (2021). An in vivo genome‐wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancer. Molecular oncology. 15 (8), pp. 2046-2064. [Online].